Message Font: Serif | Sans-Serif
No. of Recommendations: 0
I'm getting a bit tired of posting to myself. Why is there no interest in this stock? I'll answer that tomorrow when I answer my own post. Meanwhile.... the medical reporter for the Wall St. Journal (name forgotten) had some very complimentary things to say about AHP today on CNBC. AHP, apparently, has a new drug to combat ear infections in children which will have no competition in the drug marketplace. He also had some other lauditory things to say about AHP pipeline, but I was in another room and didn't catch the names of the products. He also said that Embrel (spelling?) is a success. Overall, a very bullish outlook on this rather backburner drug stock.
Print the post  


What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.